These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9682389)
1. Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine. Sato H; Kageyama S; Imakita M; Ida M; Yamamura J; Kurokawa M; Shiraki K Vaccine; 1998 Aug; 16(13):1263-9. PubMed ID: 9682389 [TBL] [Abstract][Full Text] [Related]
2. Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine. Sato H; Yamamura Ji; Kageyama S; Kurokawa M; Shiraki K Vaccine; 2003 Dec; 22(1):15-20. PubMed ID: 14604566 [TBL] [Abstract][Full Text] [Related]
3. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus. Kutinová L; Hainz P; Ludvíková V; Maresová L; Nĕmecková S Virology; 2001 Feb; 280(2):211-20. PubMed ID: 11162835 [TBL] [Abstract][Full Text] [Related]
4. Induction of cellular immunity to varicella-zoster virus glycoproteins tested with pernasal coadministration of Escherichia coli enterotoxin in mice. Tsuji T; Shiraki K; Sato H; Sasaki K; Arita M; Kato M; Takahashi T; Ochi S; Ichinose Y; Yokochi T; Asano Y J Med Virol; 2003 Mar; 69(3):451-8. PubMed ID: 12526058 [TBL] [Abstract][Full Text] [Related]
5. Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen. Shiraki K; Sato H; Yoshida Y; Yamamura JI; Tsurita M; Kurokawa M; Kageyama S J Med Virol; 2001 Jun; 64(2):89-95. PubMed ID: 11360239 [TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis. Oliver SL; Zhou M; Arvin AM Biochem Soc Trans; 2020 Dec; 48(6):2415-2435. PubMed ID: 33259590 [TBL] [Abstract][Full Text] [Related]
7. The Glycoprotein B Cytoplasmic Domain Lysine Cluster Is Critical for Varicella-Zoster Virus Cell-Cell Fusion Regulation and Infection. Yang E; Arvin AM; Oliver SL J Virol; 2017 Jan; 91(1):. PubMed ID: 27795427 [TBL] [Abstract][Full Text] [Related]
8. Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection. Oliver SL; Yang E; Arvin AM J Virol; 2017 Jan; 91(1):. PubMed ID: 27795423 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant. Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678 [TBL] [Abstract][Full Text] [Related]
10. Functions of purified gB, gE:gI, and gH:gL, and their sialyl residues in varicella-zoster virus infection. Shiraki K; Sato H; Yamamura J; Li ZH; Yokoyama T; Hasegawa T; Okuno T; Kurokawa M; Kageyama S Arch Virol; 1997; 142(11):2295-301. PubMed ID: 9672594 [TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization. Haumont M; Jurdan M; Kangro H; Jacquet A; Massaer M; Deleersnyder V; Garcia L; Bosseloir A; Bruck C; Bollen A; Jacobs P J Med Virol; 1997 Sep; 53(1):63-8. PubMed ID: 9298734 [TBL] [Abstract][Full Text] [Related]
12. Delayed-type hypersensitivity and in vitro lymphocyte response in guinea pigs immunized with a live varicella vaccine. Shiraki K; Yamanishi K; Takahashi M; Dohi Y Biken J; 1984 Mar; 27(1):19-22. PubMed ID: 6091616 [TBL] [Abstract][Full Text] [Related]
13. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content. Bergen RE; Diaz PS; Arvin AM J Infect Dis; 1990 Nov; 162(5):1049-54. PubMed ID: 2172393 [TBL] [Abstract][Full Text] [Related]
14. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62. Lowry PW; Solem S; Watson BN; Koropchak CM; Thackray HM; Kinchington PR; Ruyechan WT; Ling P; Hay J; Arvin AM J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876 [TBL] [Abstract][Full Text] [Related]
15. Neutralizing anti-gH antibody of Varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency. Shiraki K; Daikoku T; Takemoto M; Yoshida Y; Suzuki K; Akahori Y; Okuno T; Kurosawa Y; Asano Y J Virol; 2011 Aug; 85(16):8172-80. PubMed ID: 21632752 [TBL] [Abstract][Full Text] [Related]
16. Induction of Immune Response and Protective Immunity by a Local Isolated Varicella Virus in Animal Model: A Future Candidates for Vaccine Production. Esna-Ashari F; Sabahi F; Ravanshad M; Mohammadi A Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):586-593. PubMed ID: 30644703 [TBL] [Abstract][Full Text] [Related]
17. Experimental infection and immune response of guinea pigs with varicella-zoster virus. Matsunaga Y; Yamanishi K; Takahashi M Infect Immun; 1982 Aug; 37(2):407-12. PubMed ID: 6288560 [TBL] [Abstract][Full Text] [Related]
18. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection. Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506 [TBL] [Abstract][Full Text] [Related]
19. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects. Giller RH; Winistorfer S; Grose C J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419 [TBL] [Abstract][Full Text] [Related]
20. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster. Berger R; Luescher D; Just M; D'Hondt E; Bogaert H Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]